90Y radioembolization of colorectal hepatic metastases using glass microspheres: safety and survival outcomes from a 531-patient multicenter study

…, J Kallini, A Gabr, B Gorodetski… - Journal of nuclear …, 2016 - Soc Nuclear Med
Hepatic metastases of colorectal carcinoma are a leading cause of cancer-related mortality.
Most colorectal liver metastases become refractory to chemotherapy and biologic agents, at …

Intra-arterial therapy of neuroendocrine tumour liver metastases: comparing conventional TACE, drug-eluting beads TACE and yttrium-90 radioembolisation as …

D Do Minh, J Chapiro, B Gorodetski, Q Huang, C Liu… - European …, 2017 - Springer
Objectives To compare efficacy, survival outcome and prognostic factors of conventional
transarterial chemoembolisation (cTACE), drug-eluting beads TACE (DEB-TACE) and yttrium-…

Advanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization

B Gorodetski, J Chapiro, R Schernthaner, R Duran… - European …, 2017 - Springer
Objectives Our study sought to compare the overall survival in patients with hepatocellular
carcinoma (HCC) and portal venous thrombosis (PVT), treated with either conventional trans-…

Identifying staging markers for hepatocellular carcinoma before transarterial chemoembolization: comparison of three-dimensional quantitative versus non–three …

…, MD Lin, RE Schernthaner, Z Wang, B Gorodetski… - Radiology, 2015 - pubs.rsna.org
Purpose To test and compare the association between radiologic measurements of lesion
diameter, volume, and enhancement on baseline magnetic resonance (MR) images with …

Transarterial chemoembolization in soft-tissue sarcoma metastases to the liver–The use of imaging biomarkers as predictors of patient survival

…, T Schlachter, R Schernthaner, B Gorodetski… - European journal of …, 2015 - Elsevier
Background The clinical management of patients with metastatic soft-tissue sarcoma of the
liver is complicated by the paucity of reliable clinical data. This study evaluated the safety …

Preclinical benefit of hypoxia-activated intra-arterial therapy with evofosfamide in liver cancer

…, CF Brayton, TC Cornish, B Gorodetski… - Clinical Cancer …, 2017 - AACR
Purpose: To evaluate safety and characterize anticancer efficacy of hepatic hypoxia-activated
intra-arterial therapy (HAIAT) with evofosfamide in a rabbit model. Experimental Design: …

How I do it: a practical database management system to assist clinical research teams with data collection, organization, and reporting

…, R Schernthaner, R Duran, Z Wang, B Gorodetski… - Academic radiology, 2015 - Elsevier
Rationale and Objectives The objective of this study was to demonstrate that an intra-arterial
liver therapy clinical research database system is a more workflow efficient and robust tool …

Aortic valve pathology in patients supported by continuous-flow left ventricular assist device

T Saito, K Wassilew, B Gorodetski, J Stein, V Falk… - Circulation …, 2016 - jstage.jst.go.jp
Background: Continuous-flow left ventricular assist devices (CF-LVAD) may induce pathological
changes to the aortic wall and aortic valve. We assessed histological changes in the …

[HTML][HTML] Improved visibility of metastatic disease in the liver during intra-arterial therapy using delayed arterial phase cone-beam CT

…, JH Sohn, J Chapiro, Y Zhao, B Gorodetski… - Cardiovascular and …, 2016 - Springer
Purpose To compare the visibility of liver metastases on dual-phase cone-beam CT (DP-CBCT)
and digital subtraction angiography (DSA), with reference to preinterventional contrast-…

[HTML][HTML] Inferring FDG-PET-positivity of lymph node metastases in proven lung cancer from contrast-enhanced CT using radiomics and machine learning

B Gorodetski, PH Becker, ADJ Baur… - European Radiology …, 2022 - Springer
Background We evaluated the role of radiomics applied to contrast-enhanced computed
tomography (CT) in the detection of lymph node (LN) metastases in patients with known lung …